Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Tiefenbacher Pharmaceuticals is a leading global provider of generic pharmaceuticals and value-added medicines, headquartered in Hamburg, Germany. Established in 1963, the company specializes in the development, registration, and distribution of finished dosage forms across a wide array of therapeutic areas. They operate primarily through a B2B model, offering end-to-end services that include API sourcing, formulation development, and regulatory support to international partners. Tiefenbacher is particularly recognized for its expertise in complex generics and innovative drug delivery technologies. The company maintains a significant global footprint with research and development centers in both Europe and Asia. Their portfolio supports healthcare systems by providing cost-effective alternatives to brand-name medications while maintaining high quality standards.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Tiefenbacher Pharmaceuticals.